Oral semaglutide in the management of type 2 diabetes: A report on the evidence to date
Recent and Emerging Anti-diabetes Targets
Possible drug interaction between GLP-1 agonists and oral contraceptives
Mitochondrial and nuclear mutations leading to a disruption of mitochondrial function are expected to be harmful in the context of immunity, and indeed, the evidence from systemic mitochondrial disorders suggests that such disruptions lead to immunodeficiency (reviewed in [14])
How to interpret gastric emptying scintigraphy
Effect of Semaglutide on Gut Microbiota As a dynamic interface between diet, host metabolism, and drug response, the intestinal microbiota represents a critical, yet often overlooked, factor in the personalisation of obesity treatment